Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Jul;34(7):974–976. doi: 10.1136/gut.34.7.974

Serum concentrations of laminin in cirrhosis of the liver.

J Collazos 1, F Díaz 1, J Genollá 1
PMCID: PMC1374237  PMID: 8344586

Abstract

Laminin, a glycoprotein synthesised by Ito cells, has been considered a marker of fibrogenesis. The behaviour of laminin and clinical and laboratory data in 83 patients with cirrhosis were studied to find the factors associated with increases in this glycoprotein. There were increased concentrations of laminin in 62.7% of the patients (40% of the Child's A, 64.5% of the Child's B, and 75% of the Child's C categories). Significant differences in laminin concentrations were found between the Child's grades (p = 0.009) and between patients and controls (p < 0.0001). Correlations were found between laminin concentrations and mean corpuscular volume, aspartate aminotransferase, aspartate aminotransferase: alanine aminotransferase ratio, alkaline phosphatase activity, bilirubin and glycocholic acid concentrations, and hypoalbuminaemia--that is, variables related to liver insufficiency and alcohol intake. Moreover, patients with an alcohol intake higher than 100 g/day had higher laminin concentrations than those with a lower intake (p = 0.03). Conversely, there was no significant association with portal hypertension. Multivariate analysis showed that mean corpuscular volume, bilirubin concentrations, and hypoalbuminaemia were independently associated with laminin concentrations. Poor degradation associated with liver insufficiency seems to play an important part in the increase in serum laminin concentrations in these patients.

Full text

PDF
974

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annoni G., Colombo M., Cantaluppi M. C., Khlat B., Lampertico P., Rojkind M. Serum type III procollagen peptide and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology. 1989 May;9(5):693–697. doi: 10.1002/hep.1840090506. [DOI] [PubMed] [Google Scholar]
  2. Chopra S., Griffin P. H. Laboratory tests and diagnostic procedures in evaluation of liver disease. Am J Med. 1985 Aug;79(2):221–230. doi: 10.1016/0002-9343(85)90013-0. [DOI] [PubMed] [Google Scholar]
  3. Christensen E., Schlichting P., Fauerholdt L., Gluud C., Andersen P. K., Juhl E., Poulsen H., Tygstrup N. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology. 1984 May-Jun;4(3):430–435. doi: 10.1002/hep.1840040313. [DOI] [PubMed] [Google Scholar]
  4. Festi D., Morselli Labate A. M., Roda A., Bazzoli F., Frabboni R., Rucci P., Taroni F., Aldini R., Roda E., Barbara L. Diagnostic effectiveness of serum bile acids in liver diseases as evaluated by multivariate statistical methods. Hepatology. 1983 Sep-Oct;3(5):707–713. doi: 10.1002/hep.1840030514. [DOI] [PubMed] [Google Scholar]
  5. Gressner A. M. Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Clin Biochem. 1991 May;29(5):293–311. [PubMed] [Google Scholar]
  6. Gressner A. M., Tittor W., Kropf J. The predictive value of serum laminin for portal hypertension in chronic liver diseases. Hepatogastroenterology. 1988 Jun;35(3):95–100. [PubMed] [Google Scholar]
  7. Gressner A. M., Tittor W., Negwer A., Pick-Kober K. H. Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases. Clin Chim Acta. 1986 Dec 30;161(3):249–258. doi: 10.1016/0009-8981(86)90008-2. [DOI] [PubMed] [Google Scholar]
  8. Gressner A. M., Tittor W., Negwer A. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions. Hepatogastroenterology. 1986 Oct;33(5):191–195. [PubMed] [Google Scholar]
  9. Gressner A. M., Tittor W. Serum laminin--its concentration increases with portal hypertension in cirrhotic liver disease. Klin Wochenschr. 1986 Dec 1;64(23):1240–1248. doi: 10.1007/BF01734467. [DOI] [PubMed] [Google Scholar]
  10. Kropf J., Gressner A. M., Negwer A. Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases. Clin Chem. 1988 Oct;34(10):2026–2030. [PubMed] [Google Scholar]
  11. Maher J. J., Friedman S. L., Roll F. J., Bissell D. M. Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture. Gastroenterology. 1988 Apr;94(4):1053–1062. doi: 10.1016/0016-5085(88)90566-5. [DOI] [PubMed] [Google Scholar]
  12. Mal F., Hartmann D. J., Trinchet J. C., Lacombe F., Ville G., Beaugrand M. Laminine sérique et pression portale au cours de la cirrhose alcoolique. Une étude chez 39 malades. Gastroenterol Clin Biol. 1988 Nov;12(11):841–844. [PubMed] [Google Scholar]
  13. Niemelä O., Risteli J., Blake J. E., Risteli L., Compton K. V., Orrego H. Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology. 1990 Jun;98(6):1612–1619. doi: 10.1016/0016-5085(90)91098-q. [DOI] [PubMed] [Google Scholar]
  14. Nouchi T., Worner T. M., Sato S., Lieber C. S. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease. Alcohol Clin Exp Res. 1987 Jun;11(3):287–291. doi: 10.1111/j.1530-0277.1987.tb01309.x. [DOI] [PubMed] [Google Scholar]
  15. Plebani M., Burlina A. Biochemical markers of hepatic fibrosis. Clin Biochem. 1991 Jun;24(3):219–239. doi: 10.1016/0009-9120(91)80013-s. [DOI] [PubMed] [Google Scholar]
  16. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  17. Robert P., Champigneulle B., Kreher I., Gueant J. L., Foliguet B., Dollet J. M., Bigard M. A., Gaucher P. Evaluation of fibrosis in the disse space in noncirrhotic alcoholic liver disease. Alcohol Clin Exp Res. 1989 Apr;13(2):176–180. doi: 10.1111/j.1530-0277.1989.tb00306.x. [DOI] [PubMed] [Google Scholar]
  18. Rohde H., Wick G., Timpl R. Immunochemical characterization of the basement membrane glycoprotein laminin. Eur J Biochem. 1979 Dec;102(1):195–201. doi: 10.1111/j.1432-1033.1979.tb06280.x. [DOI] [PubMed] [Google Scholar]
  19. Schneider M., Voss B., Högemann B., Eberhardt G., Gerlach U. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis. Hepatogastroenterology. 1989 Dec;36(6):506–510. [PubMed] [Google Scholar]
  20. Smedsrød B., Paulsson M., Johansson S. Uptake and degradation in vivo and in vitro of laminin and nidogen by rat liver cells. Biochem J. 1989 Jul 1;261(1):37–42. doi: 10.1042/bj2610037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Thomas P., Zamcheck N. Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA). Dig Dis Sci. 1983 Mar;28(3):216–224. doi: 10.1007/BF01295116. [DOI] [PubMed] [Google Scholar]
  22. van Zanten R. A., van Leeuwen R. E., Wilson J. H. Serum procollagen III N-terminal peptide and laminin P1 fragment concentrations in alcoholic liver disease and primary biliary cirrhosis. Clin Chim Acta. 1988 Oct 14;177(2):141–146. doi: 10.1016/0009-8981(88)90135-0. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES